Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol

Minakshi Nihal; Jianqiang Wu; Connor J. Stonesifer; Jay Daniels; Jaehyuk Choi; Larisa Geskin; Alain H. Rook; Gary S. Wood

doi:10.1016/j.jid.2021.06.034

Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol

Minakshi Nihal^*, Jianqiang Wu, Connor J. Stonesifer, Jay Daniels, Jaehyuk Choi, Larisa Geskin, Alain H. Rook, Gary S. Wood

^*Corresponding author for this work

Dermatology

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	493-496.e7
Journal	Journal of Investigative Dermatology
Volume	142
Issue number	2
DOIs	https://doi.org/10.1016/j.jid.2021.06.034
State	Published - Feb 2022

ASJC Scopus subject areas

Biochemistry
Molecular Biology
Dermatology
Cell Biology

Access to Document

10.1016/j.jid.2021.06.034

Cite this

@article{8f59e27dda62409a91e2a1d5be912734,

title = "Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol",

author = "Minakshi Nihal and Jianqiang Wu and Stonesifer, {Connor J.} and Jay Daniels and Jaehyuk Choi and Larisa Geskin and Rook, {Alain H.} and Wood, {Gary S.}",

note = "Funding Information: This work was supported by the Martin and Dorothy Spatz Charitable Foundation (Sebastopol, CA), The Dennis Swatek Family Fund, and the University of Wisconsin Skin Diseases Research Center (Madison, WI) ( National Institute of Arthritis and Musculoskeletal and Skin Diseases P30-AR066524). ",

year = "2022",

month = feb,

doi = "10.1016/j.jid.2021.06.034",

language = "English (US)",

volume = "142",

pages = "493--496.e7",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma

T2 - Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol

AU - Nihal, Minakshi

AU - Wu, Jianqiang

AU - Stonesifer, Connor J.

AU - Daniels, Jay

AU - Choi, Jaehyuk

AU - Geskin, Larisa

AU - Rook, Alain H.

AU - Wood, Gary S.

N1 - Funding Information: This work was supported by the Martin and Dorothy Spatz Charitable Foundation (Sebastopol, CA), The Dennis Swatek Family Fund, and the University of Wisconsin Skin Diseases Research Center (Madison, WI) ( National Institute of Arthritis and Musculoskeletal and Skin Diseases P30-AR066524).

PY - 2022/2

Y1 - 2022/2

UR - http://www.scopus.com/inward/record.url?scp=85113309133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85113309133&partnerID=8YFLogxK

U2 - 10.1016/j.jid.2021.06.034

DO - 10.1016/j.jid.2021.06.034

M3 - Article

C2 - 34358529

AN - SCOPUS:85113309133

SN - 0022-202X

VL - 142

SP - 493-496.e7

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 2

ER -

Epigenetic Regulation of Apoptosis in Cutaneous T-Cell Lymphoma: Implications for Therapy with Methotrexate, Jak Inhibitors, and Resveratrol

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this